AlphaYou read
Insider Buy
C-suite insider bought $22K of ASND this 14d.
C-suite insider bought $22K of ASND this 14d.
Conviction is weak; save it and wait for stronger confirmation.
Saved Jun 4, 2026. Day 7 of 30D; +0.0% vs S&P so far.
- Smart money3.6/40
- Fundamentals15.2/35
- Technicals0.0/15
- Macro0.0/10
Price
Stock chart
Snapshot
Quick facts
- Market cap
- $12.71B
- P/E ratio
- 23.60
- Forward P/E
- 12.39
- Beta
- 0.48
- 52-week range
- $160.86 - $250.74
- Dividend yield
- --
- Volume
- 4.87M
- Sector
- HEALTHCARE
Analysts
What do analysts expect?
Current
$225.18
Target
$296.45
Saved calls
Recent AlphaYou calls for this stock
- LONGJun 4Insider Buy
C-suite insider bought $22K of ASND this 14d.
Public call·Results pending - LONGJun 2Insider Cluster
C-suite + 1 other insiders bought $167K of ASND this 14d.
Public call·Results pending - LONGMay 29Insider Buy
Insider bought $95K of ASND this 14d.
Public call·Results pending
Smart money
What big buyers and insiders are doing
insider buy
EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $22K
insider buy
EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $56K
insider buy
Director BIENAIME JEAN JACQUES bought $112K
insider buy
Director BIENAIME JEAN JACQUES bought $95K
short interest change
Short interest fell -22.5% as of 2026-04-30 (twice-monthly FINRA)
Top trader activity
PendingReal trader activity will show here once the feed is ready.
BTC Astro risk regime
PendingA broad risk read. Used only as context, not as the main stock reason.
Who helped?
Sources tied to past calls on this stock
Source types
- SEC EDGAR Form 4
Source family
D7
171
+1.87%
60.2% hit
D15
118
+2.76%
65.3% hit
D30
pending
Funds, insiders, and filers
- BIENAIME JEAN JACQUES
INSIDER
D7
2
-4.24%
50.0% hit
D15
pending
D30
pending
- SMITH SCOTT THOMAS
INSIDER
D7
1
+0.41%
100.0% hit
D15
pending
D30
pending
Did it work?
How past calls did
No results yet for this stock.
Results appear 7, 15, and 30 days after a call.
Each row shows what happened after the call. Green means it beat the comparison; red means it lagged.
Source links
Can you check the original source?
Fundamentals
Is the business strong?
Valuation
- P/E23.60
- Forward P/E12.39
- P/S14.69
- P/B23.83
Quality
- Profit margin57.3%
- Operating margin10.1%
- ROE33.3%
- ROA-0.6%
Growth
- Revenue YoY--
- Earnings YoY--
- Beta0.48
- Dividend yield--
Technicals
Chart health
Trailing returns
- 5d+1.11%
- 20d-0.61%
- 60d+0.53%
Trend vs moving averages
- vs SMA50+0.14%
- vs SMA200+0.41%
52w range position
Based on daily price data. Options flow and order-book data are not in this chart panel yet.
Macro
Market backdrop
- +15.3
macro regime shift
VIX 15.3 (low volatility) as of 2026-05-29
- +0.5
macro regime shift
10y-2y spread 47bps (flattish) as of 2026-05-29
- +102.5
macro regime shift
Industrial Production 102.5 (mild expansion) as of 2026-04-01
- +1.0
macro regime shift
Initial claims 215,000 vs 26w mean (ratio 1.01, neutral)
- +4.0
macro regime shift
CPI YoY 3.95% (hot vs Fed target)
Earnings
Did earnings help or hurt?
No earnings history yet for this stock.
Past earnings will show here when they are ready.
Bull vs bear
What could help or hurt?
Bullish view
- EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $22K
- EVP & Chief Financial Officer SMITH SCOTT THOMAS bought $56K
- Director BIENAIME JEAN JACQUES bought $112K
- Director BIENAIME JEAN JACQUES bought $95K
Bearish view
No reasons on this side yet.
Reasons come from smart money, fundamentals, technicals, and macro. Counts show how many reasons sit on each side.
Scorecard
Past call results
vs SPY
S&P 500
Typical edge
-4.24%
Avg edge
-4.24%
Hit rate
50.0%
Mean return
-6.96%
vs QQQ
Nasdaq-100
Typical edge
-2.14%
Avg edge
-2.14%
Hit rate
50.0%
Mean return
-6.96%
Results are grouped by stock, direction, and day so the same call is not counted twice.